NPT1 inhibitors belong to a distinctive chemical class primarily characterized by their ability to modulate the activity of the sodium-dependent phosphate transporter 1 (NPT1). This transporter, encoded by the SLC17A1 gene, plays a crucial role in regulating phosphate homeostasis within the body by facilitating the cellular uptake of inorganic phosphate. The chemical structure of NPT1 inhibitors is diverse, with a variety of compounds falling under this class. These inhibitors typically interfere with the normal function of NPT1 by binding to specific sites on the transporter protein, thereby impeding its ability to transport phosphate ions across cellular membranes.
NPT1 inhibitors hinges on their capacity to disrupt the delicate balance of phosphate absorption and excretion, which is vital for various physiological processes, including bone mineralization, cellular energy metabolism, and intracellular signaling. By selectively targeting NPT1, these inhibitors offer a means to manipulate phosphate transport dynamics, potentially influencing cellular phosphate levels. The development of NPT1 inhibitors has gained attention due to their potential impact on phosphate-related disorders. Understanding the intricate mechanisms by which these inhibitors modulate phosphate transport may shed light on novel avenues for research and development in the future. Despite ongoing investigations, the comprehensive characterization of NPT1 inhibitors and their broader implications in cellular physiology remains an active area of scientific inquiry.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Probenecid | 57-66-9 | sc-202773 sc-202773A sc-202773B sc-202773C | 1 g 5 g 25 g 100 g | $28.00 $39.00 $100.00 $277.00 | 28 | |
Competitively inhibits various anion transporters, potentially reducing the function of SLC17 family members. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
Non-selectively inhibits various membrane proteins, possibly altering SLC17A1-related transport. | ||||||
Indomethacin | 53-86-1 | sc-200503 sc-200503A | 1 g 5 g | $29.00 $38.00 | 18 | |
Inhibits anion transporters indirectly by affecting prostaglandin synthesis, altering renal transport dynamics. | ||||||
5-Nitro-2-(3-phenylpropylamino)benzoic Acid (NPPB) | 107254-86-4 | sc-201542 sc-201542B sc-201542A | 10 mg 25 mg 50 mg | $109.00 $193.00 $317.00 | 7 | |
Blocks various chloride channels and anion transporters, potentially affecting SLC17A1. | ||||||
Furosemide | 54-31-9 | sc-203961 | 50 mg | $41.00 | ||
A loop diuretic that inhibits the NKCC2, can have secondary effects on phosphate transport. | ||||||
Bumetanide (Ro 10-6338) | 28395-03-1 | sc-200727 sc-200727A | 1 g 5 g | $109.00 $228.00 | 9 | |
Similar to Furosemide, inhibits NKCC2 which could indirectly influence SLC17A1 activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Affects inositol monophosphatase leading to changes in anion transport, could alter SLC17A1 function. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $33.00 | ||
Alters lipid metabolism and can influence membrane transporters by modifying membrane properties. | ||||||
Hydrochlorothiazide | 58-93-5 | sc-207738 sc-207738A sc-207738B sc-207738C sc-207738D | 5 g 25 g 50 g 100 g 250 g | $55.00 $240.00 $333.00 $562.00 $988.00 | ||
A thiazide diuretic that affects electrolyte reabsorption, could indirectly affect SLC17A1-related transport. | ||||||
Chlorothiazide | 58-94-6 | sc-202536 sc-202536A sc-202536B | 1 g 5 g 10 g | $39.00 $107.00 $175.00 | ||
Similar to Hydrochlorothiazide, could have an indirect effect on SLC17A1 activity by altering ion balance. | ||||||